Physician profile
Khursheed Banglawala
NPI 1720035546
$1,303.26
in general payments reported to CMS, 2019-2025
21 companies · $399 in 2025
The $399 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $575 · 2020: $96.93 · 2022: $72.87 · 2024: $160 · 2025: $399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $558.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $558.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $314.01 | 2019-2025 | Farxiga |
| Novo Nordisk INC | $204.67 | 2019-2025 | Wegovy |
| Inari Medical, INC. | $140.38 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Genzyme Corporation | $124.98 | 2025 | |
| Pfizer INC. | $75.06 | 2019-2025 | |
| Glaxosmithkline, LLC. | $58.29 | 2019-2025 | Trelegy Ellipta |
| Boston Scientific Corporation | $54.76 | 2019-2022 | |
| Lilly USA, LLC | $43.73 | 2019 | |
| Genentech USA, INC. | $39.09 | 2019 | |
| Amgen INC. | $38.00 | 2025 | Repatha, Otezla |
| Medtronic, INC. | $36.41 | 2022 | |
| Neuronetics, INC. | $23.62 | 2020 | |
| Dexcom, INC. | $19.90 | 2025 | Dexcom G6 Transmitter |
| Ge Healthcare | $19.23 | 2024 | |
| Shield Therapeutics INC | $19.08 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $18.15 | 2019 | |
| Exact Sciences Corporation | $16.17 | 2025 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $16.08 | 2019 | |
| Astellas Pharma US INC | $14.93 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.32 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khursheed Banglawala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.